These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33511144)

  • 1. Association Between Use of Anti-gout Preparations and Dementia: Nested Case-Control Nationwide Population-Based Cohort Study.
    Chuang TJ; Wang YH; Wei JC; Yeh CJ
    Front Med (Lausanne); 2020; 7():607808. PubMed ID: 33511144
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-gout Medications and Risk of Cardiovascular Disease: A Nested Case-Control Study.
    Chuang TJ; Wang YH; Wei JC; Yeh CJ
    Front Med (Lausanne); 2021; 8():739680. PubMed ID: 34733863
    [No Abstract]   [Full Text] [Related]  

  • 3. Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus.
    Chang HW; Lin YW; Lin MH; Lan YC; Wang RY
    PLoS One; 2019; 14(1):e0210085. PubMed ID: 30615649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study.
    Lin HC; Daimon M; Wang CH; Ho Y; Uang YS; Chiang SJ; Wang LH
    Int J Cardiol; 2017 Apr; 233():85-90. PubMed ID: 28202260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout.
    Eun Y; Han H; Kim K; Kang S; Lee S; Kim H; Lee J; Koh EM; Cha HS
    Ther Adv Musculoskelet Dis; 2022; 14():1759720X221116409. PubMed ID: 35966182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia.
    Lai SW; Liao KF; Kuo YH; Liu CS; Hwang BF
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Usage of Colchicine and Pneumonia: A Nationwide, Population-Based Cohort Study.
    Tsai TL; Wei JC; Wu YT; Ku YH; Lu KL; Wang YH; Chiou JY
    Front Pharmacol; 2019; 10():908. PubMed ID: 31474864
    [No Abstract]   [Full Text] [Related]  

  • 8. Gout and the risk of dementia: a nationwide population-based cohort study.
    Hong JY; Lan TY; Tang GJ; Tang CH; Chen TJ; Lin HY
    Arthritis Res Ther; 2015 May; 17(1):139. PubMed ID: 26018424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of urolithiasis associated with allopurinol versus benzbromarone among patients with gout: a population-based cohort study.
    Kang EH; Shin A; Park CS; Lee EB; Lee YJ; Curhan G; Choi HK
    Rheumatology (Oxford); 2024 Sep; 63(9):2433-2441. PubMed ID: 38733596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Gout and Dementia in the Elderly: A Nationwide Population-Based Cohort Study.
    Min KH; Kang SO; Oh SJ; Han JM; Lee KE
    Am J Geriatr Psychiatry; 2021 Dec; 29(12):1177-1185. PubMed ID: 33593591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK; van Roon EN; Jansen TL; Delsing J; Griep EN; Hoekstra M; van de Laar MA; Brouwers JR
    Ann Rheum Dis; 2009 Jan; 68(1):51-6. PubMed ID: 18250112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Incidence of Stroke in Patients with Gout Using Benzbromarone.
    Niu SW; Hung CC; Lin HY; Kuo IC; Huang JC; He JS; Wen ZH; Liang PI; Chiu YW; Chang JM; Hwang SJ
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of gout medications and risk of cataract: a population-based case-control study.
    Li YJ; Perng WT; Tseng KY; Wang YH; Wei JC
    QJM; 2019 Nov; 112(11):841-846. PubMed ID: 31286139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased incidence of diabetes in patients with gout using benzbromarone.
    Niu SW; Chang KT; Ta A; Chang YH; Kuo IC; Hung CC; Chiu YW; Hwang SJ; Lin SF; Lin HY
    Rheumatology (Oxford); 2018 Sep; 57(9):1574-1582. PubMed ID: 29796661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
    Reinders MK; van Roon EN; Houtman PM; Brouwers JR; Jansen TL
    Clin Rheumatol; 2007 Sep; 26(9):1459-65. PubMed ID: 17308859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study.
    Chou HW; Chiu HT; Tsai CW; Ting IW; Yeh HC; Huang HC; Kuo CC;
    Nephrol Dial Transplant; 2018 Sep; 33(9):1620-1627. PubMed ID: 29165620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Clinical Association Between Gout and Dementia: A Nationwide Population-Based Cohort Study in Korea.
    Kim JH; Yim DH; Choi IA; Lee J; Park H; Eom SY
    Arthritis Care Res (Hoboken); 2023 May; 75(5):1088-1094. PubMed ID: 35604886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia.
    Lai SW; Liao KF; Kuo YH; Lin CL; Liu CS; Hwang BF
    Front Pharmacol; 2021; 12():731370. PubMed ID: 34658871
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
    Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E
    Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization patterns of antihyperuricemic agents following safety announcement on allopurinol and benzbromarone by Taiwan Food and Drug Administration.
    Cheng CL; Chao PH; Hsu JC; Weng MM; On AW; Yang YH
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):309-13. PubMed ID: 24307655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.